Key result
, no (). No new claims.
Case Report (n=1)
Reports a novel PRKAR1A gene variant in a patient with Carney complex and malignant psammomatous melanotic schwannoma.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to PRKAR1A variants in Carney complex with schwannomas; extends spectrum but leaves causality open.
Carney complex (CNC) is an autosomal dominant multiple neoplasm syndrome, characterized by the presence of endocrine and non-endocrine tumors; it includes myxomas, lentigines and primary pigmented nodular adrenocortical disease, among other signs/symptoms. In CNC type 1, inactivating mutations of the PRKAR1A gene were identified as the main cause of the disease, although since 2015 variants in other genes, including PRKACA and PRKACB, have also been linked to this pathology. PKA is an enzyme involved in the G protein-coupled intracellular pathways and serves as a mediator of c-AMP actions that promote cell metabolism, proliferation and apoptosis. The penetrance of CNC due to pathogenic variants in the PRKAR1A gene is close to 100%. We present the case of a 33-year-old female patient with cutaneous and mucosal lentiginosis, blue nevus, malignant melanocytic psammomatous schwannoma, cutaneous myxoma and a novel variant in the PRKAR1A gene.
No takes yet. Share an insight, caveat, or question.
Ares et al. (2026) conducted a case report in Carney complex (n=1). A novel variant in the PRKAR1A gene was identified in a 33-year-old female patient presenting with Carney complex and malignant melanocytic psammomatous schwannoma.
Synapse has enriched 10 related papers. Consider them for comparative context: